Rezultati pretrage - Guntram Schernthaner

  • Prikaz rezultata 1 – 10 od 10
Detaljiziraj rezultate
  1. 1
    Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)

    Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) od Guntram Schernthaner

    Izdano 2021-07-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  2. 2
    The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?

    The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence? od Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner

    Izdano 2021-10-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  3. 3
    Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures

    Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures od Johanna Maria Brix, Hans-Peter Kopp, Florian Höllerl, Gerit Holger Schernthaner, Bernhard Ludvik, Guntram Schernthaner

    Izdano 2019-06-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  4. 4
    Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes

    Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes od Katarzyna Krzyzanowska, Friedrich Mittermayer, Gerit H. Schernthaner, Simon Brunner, Johanna M. Brix, Stefan Aschauer, Florian Höllerl, Michael Wolzt, Guntram Schernthaner

    Izdano 2011-01-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  5. 5
    Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.

    Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly. od Julia Szendroedi, Elisabeth Zwettler, Albrecht Ingo Schmid, Marek Chmelik, Giovanni Pacini, Gertrud Kacerovsky, Gerhard Smekal, Peter Nowotny, Oswald Wagner, Christoph Schnack, Guntram Schernthaner, Klaus Klaushofer, Michael Roden

    Izdano 2008-01-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  6. 6
    Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

    Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG) od Guntram Schernthaner, Roger Lehmann, Martin Prázný, Leszek Czupryniak, Kristine Ducena, Peter Fasching, Andrej Janež, Avraham Karasik, Peter Kempler, Emil Martinka, Marina V. Shestakova, Lea Smirčić Duvnjak, Tsvetalina Tankova

    Izdano 2017-10-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  7. 7
    SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class

    SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class od Guntram Schernthaner, Heinz Drexel, Evgeny Moshkovich, Birute Zilaitiene, Emil Martinka, Leszek Czupryniak, Tamás Várkonyi, Andrej Janež, Kristine Ducena, Katarina Lalić, Tsvetalina Tankova, Martin Prázný, Lea Smirčić Duvnjak, Olga Sukhareva, Harald Sourij

    Izdano 2019-06-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  8. 8
    Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

    Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes od Guntram Schernthaner, Naim Shehadeh, Alexander S. Ametov, Anna V. Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M. Lalić, Boris Mankovsky, Emil Martinka, Dario Rahelić, Cristian Serafinceanu, Jan Škrha, Tsvetalina Tankova, Žydrūnė Visockienė

    Izdano 2020-10-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  9. 9
    Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs

    Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs od Guntram Schernthaner, Avraham Karasik, Agnė Abraitienė, Alexander S. Ametov, Zsolt Gaàl, Janusz Gumprecht, Andrej Janež, Susanne Kaser, Katarina Lalić, Boris N. Mankovsky, Evgeny Moshkovich, Marju Past, Martin Prázný, Gabriela Radulian, Lea Smirčić Duvnjak, Ivan Tkáč, Kārlis Trušinskis

    Izdano 2019-08-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:
  10. 10
    Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

    Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? od Guntram Schernthaner, Chaim Lotan, Elina Baltadzhieva-Trendafilova, Jonas Ceponis, Martin Clodi, Kristine Ducena, Eva Goncalvesova, Cristian Guja, Marek Honka, Andrej Janež, Nebojša Lalić, Roger Lehmann, Noémi Nyolczas, Priit Pauklin, Andrzej Rynkiewicz, Igor Sergienko, Lea Smirčić Duvnjak

    Izdano 2018-11-01
    Preuzmi cijeli tekst
    Članak
    Spremi u popis
    Spremljeno u:

Alati za pretragu: